| Literature DB >> 30224388 |
Frances H Ampt1,2, Lisa Willenberg1, Paul A Agius1,3, Matthew Chersich4, Stanley Luchters1,2,5, Megan S C Lim1,2,6.
Abstract
OBJECTIVES: To determine the incidence of unintended pregnancy among female sex workers (FSWs) in low-income and middle-income countries (LMICs).Entities:
Keywords: epidemiology; preventive medicine; public health; reproductive medicine; sexual medicine
Mesh:
Year: 2018 PMID: 30224388 PMCID: PMC6144321 DOI: 10.1136/bmjopen-2018-021779
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1PRISMA flow diagram of search results and inclusion of studies after review.28 FSWs, female sex workers; LMICs, low-income and middle-income countries; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
Characteristics of included studies
| Study | Additional sources | Country | Year started | Design | Aim | Population | N (FSWs) at baseline | Age (median)† | Current contraceptive use‡ (%) | Consistent condom use§ | Number of sex partners/frequency of sex¶ | Gender-based violence (GBV)/alcohol/other risk factor | HIV/STI prevalence |
| Outcome 1: unintended pregnancy | |||||||||||||
| Behets, | Madagascar | 2004 | Prospective cohort (with intervention). | Assess acceptability and feasibility of diaphragm use. | FSWs who use condoms inconsistently. | 91 | 28 | Any: 47% | 0% with clients in last month (inconsistent use was an inclusion criterion). | Five partners. | N/A. | Vaginitis/Pelvic inflammatory disease (PID): 8%. | |
| Behets, | Author†† | Madagascar | 2005 | RCT (pilot). | Assess acceptability and feasibility of diaphragm and microbicide use for STI prevention. | Women with high-risk sex behaviours (sex work self-reported: 81% current, 100% ever). | 192 | 29 | Any (excl. condoms): 24%. | 0% in last 2 weeks (inconsistent use was an inclusion criterion). | Six casual partners. | Ever violence from casual partner for suggesting condom: 21%. | N/A. |
| Braunstein, | Braunstein | Rwanda | 2006 | Prospective cohort. | Measure HIV incidence | HIV-uninfected women at high risk of HIV exposure (94% reported current sex work). | 397 | 24 | Any: 91%. | 21% with clients | 90 partners in past 3 months. | Forced sex ever: 19%. | CT: 5%. |
| Chersich, | Author†† | Kenya (Mombasa). | 2006 | Prospective cohort. | Assess HIV incidence and microbicide trial feasibility. | HIV-uninfected FSWs. | 386 | Mean 25.1 | Any (incl. | 21.3% in last 3 months. | N/A. | Hazardous or harmful drinking: 26.8%. | N/A. |
| Deschamps, | Deschamps | Haiti, Puerto Rico and Dominican Republic | 2009 | Prospective cohort. | Assess feasibility of establishing a high-risk cohort for HIV vaccine trials. | HIV-uninfected FSWs. | 634 | 24‡‡ | Permanent: 10.0% (excluded from pregnancy analysis). | 0.5% in last 6 months. | 447 partners in last 6 months‡‡. | Forced sex by client in last 6 months: 37.1%. | N/A. |
| Gaffoor, | Author†† | South Africa (one site of a multisite trial) | 2004 | RCT (phase 3, double blind, placebo-controlled). | Test safety and efficacy of the microbicide. Carraguard for HIV prevention. | HIV-uninfected sexuallyactive women (3% FSWs). | 41 | §§ | §§ | N/A. | §§ | N/A. |
|
| Lara, | Author†† | Dominican Republic | 2006 | Prospective cohort (with intervention). | Assess acceptability of the female condom and diaphragm, determinants of use, and impact on unprotected sex. | FSWs. | 243 | 58.8% aged 20–29 years | Any (excl. condoms): 22.2%. | 66% in last month. | N/A. | Ever had abortion: 70%. | HIV: 1%. |
| McClelland, | Author†† | Kenya (Mombasa) | 2003 | RCT (placebo-controlled, nested in an open cohort study). | Test efficacy of monthly periodic presumptive antibiotic treatment at reducing incidence of vaginal infections and promoting vaginal Lactobacillus colonisation. | HIV-uninfected FSWs. | 310 | 32 | Any (excl. condoms): 35.5%. | Median 100% coverage of sex acts in past week.‡‡ | One partner. | N/A. | GN: 0.3%. |
| Peterson, | Author†† | Ghana, Cameroon and Nigeria | 2004 | RCT (phase 2, double blind, placebo controlled). | Investigate safety and preliminary effectiveness of tenofovir disoproxil fumarate in preventing HIV infection. | HIV-uninfected women who work in hotels, bars, markets in high HIV transmission areas (areas known for sex work). | 936 | Mean 23.6‡‡ | Any (excl. condoms): 7.22%. | N/A. | Mean 21 partners in 30 days. | N/A. | Any STI in last 6 months (self-reported): 41.2%. |
| Watson-Jones, | Author†† | Tanzania | 2004 | RCT (double blind, placebo controlled). | Determine whether HSV2 suppressive therapy reduces the risk of HIV acquisition and genital shedding of HIV. | Female workers at food and recreational facilities at risk of HIV (38% FSWs). | 499 | §§ | §§ | §§ | §§ |
|
|
| Outcome 2: pregnancy (intention undefined) | |||||||||||||
| Bazzi, | Author†† | Mexico | 2010 | Prospective cohort. | Identify time varying risk factors for STI acquisition within FSWs’ intimate partnerships. | FSWs with drug use history and their steady male partners. | 212 | 33 | Any (excl. condoms): 53.3%. | Often or always: 56%. | N/A. | In last year: | HIV: 2.6%. |
| Page, | Author†† | Cambodia | 2009 | Prospective cohort. | Estimate HIV and STI prevalence, incidence and associated factors. | Young women who practice SW and/or have multiple partners (all those recruited had practiced SW). | 220 | 60.3% aged 25–29 years | Any hormonal (not LARC): 10.8%. | N/A. | Four partners in last month. | In last year: physical or sexual violence by client: 26.0%. | HIV: 16.2%. |
| Feldblum, | Feldblum | Madagascar | 2001 | RCT. | Assess impact of two condom promotion interventions. | FSWs. | 935 | Mean 28.3 | Any highly effective (excl. condoms): 16.3%. | No unprotected sex with any partners: 13.2%. | Mean 5–6 partners. | N/A. | CT: 14.6%. |
| Kaewkungwal, | Rerks-Ngarm | Thailand (two provinces) | 2003 | RCT (multisite double blind placebo controlled). | Assess the efficacy of two vaccines to prevent HIV. | HIV-uninfected women (5% FSWs). | 318 | N/A | N/A. | §§ | N/A. | §§ | N/A. |
| Kaul, | Yadav | Kenya (Nairobi) | 1998 | RCT (double blind placebo controlled). | Assess impact of monthly PPT on HIV and STI incidence. | HIV-uninfected FSWs. | 430 | 28.6‡‡ | Any hormonal (not LARCs): 39.1%. | 17.2% with casual partner.‡‡ | 15.4 partners.‡‡ | Daily alcohol: 47.6%. | CT: 9.9%. |
| Liu, | Author†† | China | 2009 | Cluster RCT. | Assess the impact of a preventive intervention for FSWs on condom use with clients and partners. | FSWs. | 750 | Mean 27.8‡‡ | LARC: 29.9%. | 43.6% in past month. | Mean 8.3 clients.‡‡ | N/A. | CT: 14.0%. |
| McClelland, | Author†† | Kenya (Mombasa) | 1993 | Open cohort. | Assess HIV-1 incidence and relationships between hormonal contraception, STIs and HIV. | HIV-infected FSWs. | 898 | 31 | Any (excl. condoms): 43.0%. | 55% in past week. | One partner. | N/A. | N/A. |
| Price, | Author†† | Kenya (Nairobi, Kilifi) | 2005 | Prospective cohort. | Describe populations at risk of HIV, including HIV incidence, in preparation for HIV trials. | HIV-uninfected women and men at risk of HIV (75% of women were FSWs). | 515 | §§ | N/A. | N/A. | N/A. |
| Any non-ulcerative STI: 9.1%. |
| Priddy, | Kenya (Nairobi) | 2008 | Prospective cohort. | Assess HIV risk behaviour and incidence, STI prevalence, vaginal practices and retention. | HIV-uninfected FSWs. | 200 | Mean 28 | Any non-barrier method: 52.0%. | N/A (only reported sometimes/always use). | Mean per day: | Sexual/physical violence related to Sex work (SW) in last month: 19.5%. | CT: 5.5%. | |
| Robb, | Author†† | Kenya, Tanzania and Uganda | 2009 | Prospective cohort. | Describe the trajectory of acute HIV infection. | HIV-uninfected women and men at high risk for HIV (64% FSWs). | 1463 | N/A | Any hormonal (incl. implant): 36.5%. | 32.6% with clients. | N/A. | Abortion in last 3 months: 0.43%. | N/A. |
| Strathdee, | Author†† | Mexico | 2008 | RCT (four-arm factorial). | Determine effectiveness of two behavioural interventions to reduce sexual and injecting risk. | HIV-uninfected FSWs who inject drugs. | 584 | 33 | Any (excl. condoms): 39.3%. | 14.9% with regular clients. | 30 clients per month. | N/A. | CT: 12.0%. |
| Van Damme, | Author†† | Benin, Cote d’Ivoire, South Africa and Thailand | 1996 | RCT (multisite triple blind placebo-controlled; open cohort design). | Determine effectiveness of nonoxynol-9 microbicide in prevention of HIV-1. | HIV-uninfected FSWs. | 892 | 26 | N/A. | N/A (only reported use of condom in ≥50% of sex acts). | Three partners per day. | N/A. | CT: 4.4%. |
| van Loggerenberg, | Author†† | South Africa (Durban) | 2004 | Prospective cohort. | Understand HIV-1 subtype C acquisition, pathogenesis and disease progression. | HIV-uninfected women who practice SW (79%) and/or have multiple partners. | 193 | Mean 34.3 | N/A. | 53.9% with casual partners. | Two partners per week. | N/A. | Any STI (CT, GN, TV, MG, TP, HSV2): 31.3%. |
| Vandepitte, | Author†† | Uganda (urban slum). | 2008 | Prospective cohort. | Understand dynamics of HIV and STI infections among FSWs. | FSWs. | 1027 | Mean 26 | N/A. | 59.8% in last month. | At least daily sex for money: 50.5%. | Problem drinking: 55.7%. | MG: 14%. |
| Vielot, | Author†† | Kenya (Nairobi) | 2009 | Prospective cohort. | Compare the duration of high risk HPV infection among FSWs by exposure to STIs, using a highly sensitive biomarker assay. | FSWs. | 350 | 28 | LARC: 15.5%. | Most of the time/always: | 10 partners per week. | N/A. | HIV: 24.0%. |
†Median unless specified.
‡Any=modern contraceptive method including condoms, unless specified; LARC=long-acting reversible contraception (implants or IUDs); Permanent=any method of permanent contraception, for example, tubal ligation or hysterectomy.
§Always uses condoms (unless specified).
¶Median number per week unless specified. Sex partners may be paying, non-paying, regular or casual, unless specified.
††‘Author’ indicates additional data were obtained from the author. Other references listed here reported on the same study and were used for data extraction.
‡‡Reported results segregated by sub-group; data presented here are overall estimates.
§§Not disaggregated by sex work status.
BV, bacterial vaginosis; CT, Chlamydia trachomatis; FSW, female sex worker; HSV2, herpes simplex virus type 2; MG, Mycoplasma genitalium; N/A, not measured or reported, data not available from author; NG, Neisseria gonorrhoeae; RCT, randomised controlled trial; STI, sexually transmitted infection; TP, Treponema pallidum (syphilis); TV, Trichomonas vaginalis.
Results of included studies reporting unintended pregnancy and pregnancy (intention undefined) in ascending order of incidence
| Study | Incidence rate (per 100 person-years) | 95% CI | Person-years of exposure | Duration (months) | Measurement of pregnancy | Frequency of measurement | Quality (%) |
| Unintended pregnancy | |||||||
| McClelland | 7.2 | 4.5 to 10.9 | 305.4 | 12 | Urine test | Monthly | 40 |
| Watson-Jones | 11.8 | 9.7 to 14.5 | 796 | 30 | Urine test | Quarterly on suspicion only | 53 |
| Gaffoor | 13.4 | 6.1 to 25.4 | 67.2 | 24 | Urine test | Quarterly | 20 |
| Behets | 20.7 | 4.3 to 60.5 | 14.5 | 1 | Urine test | Weekly | 27 |
| Braunstein | 26.3 | 21.9 to 30.7 | 528.5 | 24 | Serum test | 6 monthly for 1 year+1 measurement in second year | 60 |
| Deschamps | 27.3 | 23.3 to 31.7 | 615.6 | 18 | Test (unspecified) | 6 monthly | 67 |
| Chersich | 28.0 | 22.6 to 34.3 | 335.8 | 12 | Urine test | Quarterly | 60 |
| Peterson | 51.7 | 44.9 to 59.3 | 400 | 12 | Urine test | Monthly | 40 |
| Behets | 53.0 | 21.0 to 110.0 | 13.2 | 2 | Urine test | Monthly | 40 |
| Lara | 59.6 | 41.7 to 82.5 | 60.4 | 4 | Urine test | Monthly | 40 |
| Pregnancy (intention undefined) | |||||||
| Robb | 2.0 | 1.4 to 2.9 | 1619.6 | 24 | Self-report | Quarterly on suspicion only | 21 |
| McClelland | 2.7 | 2.1 to 3.5 | 2259.3 | 15-year open cohort | Urine test | Monthly on suspicion only | 21 |
| Bazzi | 3.3 | 1.4 to 5.2 | 359.6 | 24 | Self-report | 6 monthly | 43 |
| Strathdee | 5.9 | 4.1 to 8.4 | 540.1 | 12 | Self-report | 4 monthly | 36 |
| van Loggerenberg | 8.5 | 5.6 to 11.5 | 376.5 | 24 | Urine test | Monthly on suspicion only | 36 |
| Van Damme | 8.6 | 6.7 to 10.8 | 837.5 | ≤24 | Urine test | Quarterly | 29 |
| Vielot | 12.6 | 9.7 to 16.1 | 500.8 | 24 | Urine test | Quarterly on suspicion only | 50 |
| Kaul | 13.5 | 11.3 to 16.1 | 968.0 | ≤48 | N/A | N/A | 21 |
| Priddy | 14.2 | 7.6 to 24.3 | 91.5 | 6 | Urine test | Quarterly | 36 |
| Price | 14.5 | 12.0 to 17.5 | 784.0 | 48 | Urine test | Quarterly | 43 |
| Liu | 15.2 | 10.4 to 21.5 | 210.3 | 6 | Self-report | Quarterly | 71 |
| Kaewkungwal | 15.8 | 13.0 to 19.0 | 721.0 | 42 | Urine test | N/A | 43 |
| Vandepitte | 18.3 | 16.2 to 20.6 | 1467.0 | ≥24 | Urine test | N/A | 50 |
| Page | 22.0 | 16.3 to 30.1 | 186.4 | 12 | Self-report | Quarterly | 50 |
| Feldblum | 23.4 | 20.6 to 26.5 | 1067.5 | 18 | Urine test | 6 monthly on suspicion only | 43 |
*Duration varied for different participants.
†Person-time estimated by: (n_FSWs * yrs * retention) − (n_preg * yrs/2); where: n_FSWs, number of FSWs enrolled; yrs, study duration in years; retention, retention rate; n_p reg, number of women who became pregnant. We could not use the approach advocated by Vandenbrou c ke et al 95 as average follow-up time among FSWs was not known.
FSWs, female sex workers; N/A, not measured or reported, data not available from author.
Figure 2Incidence rates (per 100 person-years) for studies reporting unintended pregnancy.
Figure 3Forest plot showing subgroup analysis of unintended pregnancy incidence rates (per 100 person-years) by intervention versus no intervention.
Figure 4Forest plot showing subgroup analysis of unintended pregnancy incidence rates (per 100 person-years) by RCT versus cohort study design. RCT, randomised controlled study.
Figure 5Forest plot showing subgroup analysis of unintended pregnancy incidence rates (per 100 person-years) by study duration (cut-off 1 year).
Figure 6Forest plot showing subgroup analysis of pregnancy (intention undefined) incidence rates (per 100 person-years) by geographic region.
Incidence of abortion and birth
| Study | Site | Outcome | Incidence of pregnancy | Incidence of birth | Incidence of abortion | Abortion (as proportion of pregnancies with known outcome) |
| Deschamps | Haiti, Puerto Rico and Dominican Republic | Unintended pregnancy | 27.3 | 15.1 | 3.1 | 16% |
| Feldblum | Madagascar | Pregnancy (intention undefined) | 23.4 | 11.9 | 3.0 | 17% |
| Van Damme | Benin, Cote d’Ivoire, South Africa and Thailand | Pregnancy (intention undefined) | 8.6 | Not measured | 7.4 | >85% |